Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
Karin Neukam(Hospital Universitario de Valme), Juan A. Pineda(Hospital Universitario de Valme), Antonio Rivero(Hospital Universitario Reina Sofía), Ángela Camacho(Hospital Universitario Reina Sofía), Luís F. López‐Cortés(Instituto de Biomedicina de Sevilla), Jacob Nattermann(University of Bonn), Jürgen K. Rockstroh(University of Bonn), Norma Rallón, José M. Benito(Hospital Universitario Rey Juan Carlos), Almudena Torres-Cornejo(Instituto de Biomedicina de Sevilla), Jesús Gómez‐Mateos(Hospital Universitario de Valme), Antonio Carúz(Universidad de Jaén), Juan Macı́as(Hospital Universitario de Valme)
Cited by 43
Related Papers
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
|AIDS|2003|355
The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells
|American Journal Of Pathology|2005|171